UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000059294
Receipt number	R000067823
Scientific Title	A biomarker study associated with a randomized, prospective phase II trial comparing the efficacy and safety of mFOLFOX6 plus cetuximab (q2w) versus mFOLFOX6 plus bevacizumab as first-line treatment for unresectable right-sided colon cancer with RAS/BRAF wild-type
Date of disclosure of the study information	2025/10/06
Last modified on	2025/10/05 17:10:00

---